BSEAchyut Healthcare Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 17 Apr, 2025 · 18:42 IST

Disclosure for Resignation of Ms. Drashti Unadkat from the post of Company Secretary and Compliance Officer of the Company.

Kmp ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.4%Reaction day
₹3.20
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.5%+2.9% vs market
Pharmaceuticals peers, median of 148sector+0.6%+3.7% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 3.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.4+1.5+2.9+0.6+3.7
Next day
+9.4+2.4+7.0+0.9+8.5
2d
+14.7+2.4+12.3+1.6+13.1
3d
+14.4+2.8+11.6+2.8+11.6
4d
+14.1+0.1+14.0-0.8+14.9
5d
+11.9+0.0+11.8-0.9+12.8
1w
+12.2-2.3+14.4-2.6+14.7
15d
—+2.9—-0.2—
1m
+2.8+7.4-4.6+2.5+0.3
2m
+0.0+8.7-8.7+0.6-0.6
3m
+45.3+14.6+30.7+7.5+37.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Achyut Healthcare Ltd informed BSE that Ms. Drashti Unadkat has resigned from the post of Company Secretary and Compliance Officer, effective April 17, 2025. In her resignation letter, she cited the pursuit of other career opportunities and growth outside the organization as the reason. The Board accepted her resignation at its meeting held on the same day from 5:00 p.m. to 5:30 p.m. Separately, the Board also approved the migration of the company's equity shares from the BSE SME platform to the BSE Mainboard, approved related party transactions for FY 2025-26, and appointed a scrutinizer for the postal ballot process. The company has not yet announced a replacement for the Company Secretary role.

Likely market impact

A routine key managerial personnel exit with a benign stated reason. Investors should also note the separately approved move from the BSE SME platform to the Mainboard, which is generally positive for liquidity and visibility but still subject to necessary approvals.